Saturday 17 October 2026 Export URGN’s income statement to Excel — free account

Urogen Pharma

Urogen Pharma’s revenue for fiscal 2025 (year ended December 2025) was $109.8 million, up 21.4% from fiscal 2024. In the quarter to June 2026, revenue grew 199.2%, EPS grew 73.3%, free cash flow grew 17.3% and total debt rose 56.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

34.56 2.05 −5.60%

Follow URGN

Alert me

Market cap: $1.8B
P/E: 0.0×
Fwd P/E: −30.0×
Dividend yield: —
F-score: 2/9
Altman Z: −5.16
Beneish M: −1.42
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	3	3	2	2	+8 more TTM periods Free account
ROE Full definition →	86.49%	156.08%	268.63%	366.31%
ROA Full definition →	(42.33%)	(53.15%)	(63.14%)	(67.62%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(56.08%)	(71.07%)	(109.45%)	(129.64%)
Average Days of Receivables Full definition →	171.65	143.96	109.98	74.51
Free Cash Flow per Share Full definition →	(3.16)	(3.31)	(3.38)	(2.87)
Free Cash Flow Full definition →	(159.13)	(166.03)	(162.73)	(138.12)
Capital Expenditures Full definition →	(0.22)	(0.30)	(0.29)	(0.39)
Other line items
Cash ROIC Full definition →	(94.40%)	(80.26%)	(114.59%)	(102.25%)
Accounts Receivable Turnover Full definition →	3.48	3.74	4.11	4.54
Accounts Payable Turnover Full definition →	0.49	0.43	0.45	0.51
Inventory Turnover Full definition →	1.09	1.00	0.97	1.46
Average Days of Payables Full definition →	843.84	904.97	812.78	821.49
Days of Inventory on Hand Full definition →	519.45	535.65	482.80	261.80
Tax Rate Full definition →	0.00	(0.04)	0.00	0.02
Research and Development Expense of Revenue Full definition →	32.46%	44.72%	61.12%	70.13%
Selling, General and Administrative Expense of Revenue Full definition →	93.71%	122.15%	141.27%	156.04%
Share Based Compensation of Revenue Full definition →	8.54%	9.62%	10.89%	12.57%
Interest Coverage Full definition →	(4.11)	(7.00)	(8.14)	(8.63)
Operating CF/Net income Full definition →	1.63	1.24	1.06	0.84
Depreciation/Fixed assets Full definition →	(2.62)	(1.24)	(2.46)	(4.08)
Capex/Depreciation Full definition →	0.14	0.39	0.18	0.14
Revenue per Share Full definition →	3.75	2.80	2.28	2.01
Operating CF per Share Full definition →	(3.15)	(3.30)	(3.38)	(2.87)
Capex per Share Full definition →	0.00	(0.01)	(0.01)	(0.01)
Capex to Sales Full definition →	0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly